July 1, 2011

FDA approves new drug to treat C diff

By: OR Manager
Share

The Food and Drug Administration in May 2011 approved the first new drug in 25 years to treat diarrhea caused by Clostridium difficile, a pathogen that one study suggests may have surpassed methicillin-resistant Staphylococcus aureus as the leading hospital-acquired infection, according to the New York Times.

In clinical trials, fidaxomicin (Di-ficid) performed better than vancomycin, the only other drug approved to treat C diff, in keeping patients symptom-free 25 days after the end of treatment.

The drug, in tablet form, is taken twice a day for 10 days.

—www.fda.gov

Join our community

Learn More
Video Spotlight
Live chat by BoldChat